North America was Thermo Fisher Scientific’s largest region in fiscal 2025, bringing in $23.03B of $44.56B (52%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | $24.59B | $22.76B | $22.50B | $23.03B | |||||||||||||
| Europe | $10.76B | $10.74B | $10.86B | $11.83B | |||||||||||||
| United States | — | — | — | — | |||||||||||||
| Us | — | — | — | — | |||||||||||||
| Asia-Pacific | $8.12B | $7.87B | $7.96B | $8.10B | |||||||||||||
| Asia Pacific | — | — | — | — | |||||||||||||
| All Other Countries | — | — | — | — | |||||||||||||
| Segment Geographical Groups Of Countries Group One | — | — | — | — | |||||||||||||
| Other Regions | $1.44B | $1.48B | $1.56B | $1.60B | |||||||||||||
| China | — | — | — | — | |||||||||||||
| Cn | — | — | — | — | |||||||||||||
| Germany | — | — | — | — | |||||||||||||
| De | — | — | — | — | |||||||||||||
| Japan | — | — | — | — | |||||||||||||
| United Kingdom | — | — | — | — | |||||||||||||
| Gb | — | — | — | — | |||||||||||||
| Total | $44.92B | $42.86B | $42.88B | $44.56B |
Thermo Fisher Scientific brought in $44.56B from its four regions in fiscal 2025, the year ended December 31, 2025. That was up 3.9% from $42.88B in fiscal 2024. North America was the largest at $23.03B (51.7%), ahead of Europe at $11.83B (26.5%) and Asia-Pacific at $8.10B (18.2%). The remaining region, Other Regions, brought in $1.60B.
Compared with fiscal 2024, Europe grew fastest, up 8.9% to $11.83B. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions fell from $44.92B to $44.56B, a compound annual decline of 0.3%. North America's share of the total fell from 54.8% to 51.7%.
Laboratory Products & Biopharma Services was Thermo Fisher Scientific’s largest segment in fiscal 2025, bringing in $23.98B of $44.56B (54%).
| Segment | FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Products & Biopharma Services | $22.30B | $23.04B | $23.16B | $23.98B | ||||||||||||||
| Laboratory Products & Services | — | — | — | — | ||||||||||||||
| Life Sciences Solutions | $11.57B | $9.98B | $9.63B | $10.37B | ||||||||||||||
| Analytical Instruments | $6.44B | $7.26B | $7.46B | $7.55B | ||||||||||||||
| Specialty Diagnostics | $4.60B | $4.41B | $4.51B | $4.68B | ||||||||||||||
| Analytical Technologies | — | — | — | — | ||||||||||||||
| Business Intersegment Eliminations | — | — | — | — | ||||||||||||||
| Elimination Of Intersegment Revenues | — | -$1.83B | -$1.89B | -$2.03B | ||||||||||||||
| Intersegment Eliminations | — | — | — | — | ||||||||||||||
| Intersegment Elimination | — | — | — | — | ||||||||||||||
| Total | $44.91B | $42.86B | $42.88B | $44.56B |
Thermo Fisher Scientific brought in $44.56B from its five segments in fiscal 2025, the year ended December 31, 2025. That was up 3.9% from $42.88B in fiscal 2024. Laboratory Products & Biopharma Services was the largest at $23.98B (53.8%), ahead of Life Sciences Solutions at $10.37B (23.3%) and Analytical Instruments at $7.55B (17.0%). The remaining segment, Specialty Diagnostics, brought in $4.68B.
Compared with fiscal 2024, Life Sciences Solutions grew fastest, up 7.7% to $10.37B. Every segment above 2% of revenue grew.
Thermo Fisher Scientific began breaking out Elimination Of Intersegment Revenues in fiscal 2023, when it brought in -$1.83B. The total is net of Elimination Of Intersegment Revenues, which took $2.03B off revenue in fiscal 2025.
Consumables was Thermo Fisher Scientific’s largest product and service line in fiscal 2025, bringing in $18.66B of $44.56B (42%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | $20.62B | $17.60B | $17.59B | $18.66B | ||||||
| Product | — | — | — | — | ||||||
| Service Revenues | $16.37B | $17.61B | $17.85B | $18.59B | ||||||
| Service | — | — | — | — | ||||||
| Instruments | $7.92B | $7.65B | $7.45B | $7.30B | ||||||
| Total | $44.92B | $42.86B | $42.88B | $44.56B |
Thermo Fisher Scientific brought in $44.56B from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 3.9% from $42.88B in fiscal 2024. Consumables was the largest at $18.66B (41.9%), ahead of Service Revenues at $18.59B (41.7%) and Instruments at $7.30B (16.4%).
Compared with fiscal 2024, Consumables grew fastest, up 6.1% to $18.66B, while Instruments fell the most, down 1.9% to $7.30B. From fiscal 2022 to 2025, combined revenue from these lines fell from $44.92B to $44.56B, a compound annual decline of 0.3%. Consumables' share of the total fell from 45.9% to 41.9%.
Thermo Fisher Scientific (TMO) reports its revenue by geography, by segment and by product and service. In fiscal 2025, North America was its largest region, bringing in $23.03B (51.7% of the total), followed by Europe at $11.83B (26.5%).
North America was Thermo Fisher Scientific's largest region in fiscal 2025, bringing in $23.03B, or 51.7% of the $44.56B total across its four regions.
Laboratory Products & Biopharma Services was Thermo Fisher Scientific's largest segment in fiscal 2025, bringing in $23.98B, or 53.8% of the $44.56B total across its five segments.
Consumables was Thermo Fisher Scientific's largest product and service line in fiscal 2025, bringing in $18.66B, or 41.9% of the $44.56B total across its three product and service lines.
Among Thermo Fisher Scientific's regions that make up at least 2% of revenue, Europe grew fastest in fiscal 2025, up 8.9% from $10.86B to $11.83B.
Every figure comes from Thermo Fisher Scientific's annual financial filings, as reported. Each line keeps the name Thermo Fisher Scientific gives it, and years follow its fiscal calendar.
Thermo Fisher Scientific's revenue by geography goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.